These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2817767)

  • 1. [Duodenal ulcer, study of gastric secretion and rational treatment with famotidine in different doses].
    Santoro E; Morucci P; Idotta G; Scutari F
    Ann Gastroenterol Hepatol (Paris); 1989 Oct; 25(5):211-4. PubMed ID: 2817767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
    Watanabe Y; Tsumura H; Sasaki H; Morimoto T
    Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between single morning and bedtime doses of 40 mg famotidine for the treatment of duodenal ulcer.
    Marenco G; Menardo G; Pallini P; Rossini FP; Saggioro A
    Aliment Pharmacol Ther; 1989 Jun; 3(3):285-91. PubMed ID: 2520624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of roxatidine and famotidine on nocturnal gastric juice secretion.
    Tanioka H; Kaga K
    J Int Med Res; 1996; 24(1):88-91. PubMed ID: 8674804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
    Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
    Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of acid suppression in H2-antagonist nonresponders.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Celle G
    Digestion; 1992; 51(4):185-92. PubMed ID: 1356863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
    Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exogenous administration of transforming growth factor-beta and famotidine on the healing of duodenal ulcer under the impact of indomethacin.
    Pérez-Aisa A; Sopeña F; Arceiz E; Ortego J; Sainz R; Lanas A
    Dig Liver Dis; 2003 Jun; 35(6):397-403. PubMed ID: 12868675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Famotidine in the treatment of duodenal peptic ulcer].
    Bussalleu A; Berrios J; Espejo H; Espinoza R; Farfán G; Galarza J; Guerra J; Nago A; Simich C; Valladares G
    Rev Gastroenterol Peru; 1990; 10(1):27-32. PubMed ID: 2129891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
    Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.
    Delchier JC; Roudot-Thoraval F; Stanescu L; Deharvengt MC; Elouaer Blanc L
    Gut; 1994 Jun; 35(6):750-4. PubMed ID: 8020798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged gastric pH monitoring in responder and nonresponder duodenal ulcer patients: response to placebo and to H2-blocker administration.
    Masoero G; Rossanino A; Arossa W; De la Pierre M
    J Clin Gastroenterol; 1991 Jun; 13(3):291-5. PubMed ID: 1676715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Famotidine in the short and long term treatment of duodenal ulcer: clinical and physiopathologic study].
    Vio A; Pasqualetti P; Gottardello L; Grassi SA; Vianello F; Dal Santo L; Tessaro P; Di Mario F; Naccarato R
    G Clin Med; 1989 Mar; 70(3):195-201. PubMed ID: 2759390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
    Reynolds JC; Schoen RE; Maislin G; Zangari GG
    Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of duodenal ulcer with famotidine and proglumide].
    Tarabar D; Kostić M; Perisić N; Rabrenović L; Jović J; Arsić L; Lukacević S; Petrović M
    Vojnosanit Pregl; 1995; 52(6):563-7. PubMed ID: 8644481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.